13h
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...
Artificial intelligence is making its way into every aspect of life, including cancer prevention. New technology at MUSC is ...
Expanded pharmacogenomic panel enhances safety for patients receiving 5-FU and capecitabineMASON, Ohio, Jan. 5, 2026 ...
GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...
GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...
As the new year begins, students in the University of Washington (UW)’s Medical Laboratory Science (MLS) program are starting ...
Following a DLA Weapons Support audit conducted June 24–26, 2025, SMT Corp has been deemed suitable to perform a wide range ...
Quality playbook systems preparing for outpatient procedure expansion focus on protocols, outcomes tracking, and staff readiness amid CMS rule changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback